GENIL
Closed
Gen Ilac Ve Saglik Urunleri Sanayi Ve Ticaret As
58.6
+0.6 (+1.03%)
Last Update: 19 Apr 2024 18:08:00
Yesterday: 58.
Day's Range: 56.65 - 59.25
Send
sign up or login to leave a comment!
When Written:
50.2
Gen Ilac ve Saglik Urunleri Sanayi ve Ticaret AS is a pharmaceutical company based in Istanbul, Turkey. The company was founded in 1964 and is primarily engaged in the production, marketing, and distribution of prescription and non-prescription drugs, as well as medical devices and other healthcare products.
Gen Ilac operates in both the domestic and international markets, with a focus on developing and manufacturing innovative and high-quality products. The company's product portfolio includes a wide range of therapeutic areas, including cardiovascular, respiratory, gastrointestinal, and central nervous system disorders, as well as oncology, dermatology, and ophthalmology.
Gen Ilac is committed to research and development, investing heavily in new drug discovery and development. The company has a dedicated R&D center and collaborates with leading academic institutions and research organizations to advance its pipeline of products.
In addition to its pharmaceutical business, Gen Ilac also operates a medical equipment and supplies division, which provides a range of medical devices and equipment to hospitals and healthcare facilities. The company has a strong distribution network, with a presence in over 70 countries worldwide.
Overall, Gen Ilac is a leading player in the Turkish pharmaceutical industry, with a strong focus on innovation, quality, and customer service.
Note: This message was created by artificial intelligence; It does not guarantee the accuracy of the information it contains and cannot be considered as investment advice.
Gen Ilac operates in both the domestic and international markets, with a focus on developing and manufacturing innovative and high-quality products. The company's product portfolio includes a wide range of therapeutic areas, including cardiovascular, respiratory, gastrointestinal, and central nervous system disorders, as well as oncology, dermatology, and ophthalmology.
Gen Ilac is committed to research and development, investing heavily in new drug discovery and development. The company has a dedicated R&D center and collaborates with leading academic institutions and research organizations to advance its pipeline of products.
In addition to its pharmaceutical business, Gen Ilac also operates a medical equipment and supplies division, which provides a range of medical devices and equipment to hospitals and healthcare facilities. The company has a strong distribution network, with a presence in over 70 countries worldwide.
Overall, Gen Ilac is a leading player in the Turkish pharmaceutical industry, with a strong focus on innovation, quality, and customer service.
Note: This message was created by artificial intelligence; It does not guarantee the accuracy of the information it contains and cannot be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!